Brain serotonin(1A) receptor binding measured by positron emission tomography with [11C]WAY-100635: Effects of depression and antidepressant treatment

Archives of General Psychiatry

Volumn 57, Issue 2, 2000, Pages 174-180

  Sargent, Peter A ^a,b   Husted Kjaer, Karen ^a,c   Bench, Christopher J ^a,d   Rabiner, Eugenii A ^a,d   Messa, Cristina ^a,e   Meyer, Jeff ^a,f   Gunn, Roger N ^a   Grasby, Paul M ^a,d   Cowen, Philip J ^b  

^a HAMMERSMITH HOSPITAL   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c University of Copenhagen   (Denmark)

^d IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

^e UNIVERSITY OF MILAN   (Italy)

^f UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CARBON 11; N [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] N (2 PYRIDYL)CYCLOHEXANECARBOXAMIDE; PAROXETINE; SEROTONIN; SEROTONIN 1A RECEPTOR; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; ANTIDEPRESSANT AGENT; CARBON; DIAGNOSTIC AGENT; PIPERAZINE DERIVATIVE; PYRIDINE DERIVATIVE; SEROTONIN RECEPTOR;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DEPRESSION; FEMALE; FRONTAL CORTEX; HUMAN; LIMBIC CORTEX; MALE; POSITRON EMISSION TOMOGRAPHY; RECEPTOR BINDING; RECEPTOR DENSITY; TEMPORAL CORTEX; BRAIN; COMPUTER ASSISTED EMISSION TOMOGRAPHY; DRUG EFFECT; FRONTAL LOBE; LIMBIC SYSTEM; METABOLISM; MIDDLE AGED; RAPHE NUCLEUS; SCINTISCANNING; STATISTICS; TEMPORAL LOBE;

ADULT; AGED; ANTIDEPRESSIVE AGENTS; BRAIN; CARBON RADIOISOTOPES; DEPRESSIVE DISORDER; FEMALE; FRONTAL LOBE; HUMANS; LIMBIC SYSTEM; MALE; MIDDLE AGED; PIPERAZINES; PYRIDINES; RAPHE NUCLEI; RECEPTORS, SEROTONIN; TEMPORAL LOBE; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0033621542     PISSN: 0003990X     EISSN: None     Source Type: Journal    
DOI: 10.1001/archpsyc.57.2.174     Document Type: Article

References (43)

1. Deakin WJF. 5-HT, antidepressant drugs and the psychosocial origins of depression. J Psychopharmacol. 1996;10:31-38.
2. Smith KA, Cowen PJ. Serotonin and depression. In: Hening A, van Praag HM, eds. Depression: Neurobiological. Psychopathological and Therapeutic Advances. Chichester, England: John Wiley & Sons Ltd: 1997:129-146.
3. 1A receptor responsivity in anxiety disorders and in depression. Prog Neuropsychopharmacol Biol Psychiatry. 1992;15:723-733.
4. 1A receptor sensitivity in major depression: a neuroendocrine study with buspirone. Br J Psychiatry. 1994; 164:372-379.
5. Meltzer HY, Maes M. Effects of ipsapirone on a plasma cortisol and body temperature in major depression. Biol Psychiatry. 1995;38:450-457.
6. 1A receptors in major depression. J Psychopharmacol. 1990;4:69-74.
7. 1A receptor binding in the human brain postmortem: effects of age and alcohol. Brain Res. 1991;554:56-64.
8. 1A binding sites in frontal cortex of suicide victims. J Neural Transm. 1991;85:181-194
9. 1D and 5-HT2 receptors in suicide victims. Biol Psychiatry. 1994;35:457-463.
10. 1A receptor binding sites in post-mortem brain samples from depressed suicides and controls. J Aflect Disord. 1997;42:199-207.
11. Stockmeier CA, Dilley GE, Shapiro SA, Overholser JC, Thompson PA, Meltzer HY. Serotonin receptors in suicide victims with major depression. Neuropsychopharmacology. 1997;16:162-173.
12. Joyce JN, Shane A, Lexow N, Winokur A, Casanova MF, Kleinman JE. Serotonin uptake sites and serotonin receptors are altered in the limbic system of schizophrenics. Neuropsychopharmacology. 1993;8:315-336.
13. Arango V, Underwood MD, Gubbi AV, Mann JJ. Localised alterations in pre-and postsynaptic serotonin binding sites in the ventrolateral prefrontal cortex of suicide victims. Brain Res. 1995;688:121-133.
14. Stockmeier CA, Shapiro LA, Dilley GE, Kolli TN, Friedman L, Rajkowska G. Increase in serotonin-1A autoreceptors in the midbrain of suicide victims with major depression - postmortem evidence for decreased serotonin activity. J Neurosci. 1998;18:7394-7401.
15. De Montigny C, Aghajanian GK. Tricyclic antidepressants: longterm treatment increases responsivity of rat forebrain neurones to serotonin. Science. 1978; 202:1303-1306.
16. Blier P, De Montigny C, Chaput Y. Modifications of the serotonin system by antidepressant treatments: implications for the therapeutic response in major depression. J Clin Psychopharmacol. 1987;7(suppl 6):24S-35S.
17. Blier P, De Montigny C, Chaput V. A role for serotonin system in the mechanism of action of antidepressant treatments: preclinical evidence. J Clin Psychiatry. 1990;51:14-20.
18. 1A receptors in rat brain following antidepressant drug treatment. Synapse. 1989;4:347-352.
19. 1A agonist ipsapirone by long-term treatment with fluoxetine, but not desipramine, in male rats. Biol Psychiatry. 1994; 36:300-308.
20. 1A receptor regulation: effect of 5,7-dihydroxytryptamine and antidepressant treatments. Neuropsychopharmacology. 1991;4:131-144.
21. Jolas T, Haj-Dahmane S, Kidd EJ, Langlois X, Lanfumey L, Fattacini CM, Vantalon V, Laporte AM, Adrien J, Gozlan H, Hamon M. Central pre-and postsynaptic 5-HT1A receptors in rats treated chronically with a novel antidepressant, cericlamine. J Pharmacol Exp Ther. 1994;268:1432-1443.
22. 1A autoreceptors in rats treated with fluoxetine or paroxetine. Naunyn Schmiedebergs Arch Pharmacol. 1995;352:141-148.
23. 1A receptor responsivity in obsessive-compulsive disorder. Psychopharmacology. 1991;105:1415-1420.
24. 1A receptor sensitivity. Psychopharmacology. 1997; 132:296-302.
25. Fletcher A, Cliffe IA, Forster EA, Jones D, Reilly Y. A pharmacological profile of WAY-100635, a potent and selective 5-HT1A receptor antagonist. Br J Pharmacol. 1994;112:91P.
26. Gurling J, Ashworth-Preece MA, Dourish CT, Routledge C. Effects of acute and chronic treatment with the selective 5-HT1A receptor antagonist WAY-100635 on hippocampal 5-HT release in vivo. Br J Pharmacol. 1994;112:299P.
27. 11C]WAY-100635. Eur J Pharmacol 1996; 301:R5-R7.
28. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. Fourth Edition. Washington, DC: American Psychiatric Association; 1994.
29. 11 C-carboxylation of an immobilized Gringard reagent. J Label Compounds Radiopharm. 1996;38:941-953.
30. 11C]WAY-100635 for PET. Neuroimage. 1998;8:426-440.
31. Grootoonk S, Spinks TJ, Sashin D, Spyrou NM, Jones T. Correction for scatter in 3D brain PET using a dual energy window method. Phys Med Biol. 1996;41: 2757-2774.
32. Kinahan PE, Rogers JG. Analytic 3-D image reconstruction using all detected events. IEEE Trans Nucl Sci. 1989;36:964-968.
33. Lammertsma AA, Hume SP. Simplified reference tissue model for PET receptor studies. Neuroimage. 1996;4:153-158.
34. Gunn RN, Lammertsma AA, Hume SP, Cunningham VJ. Parametric imaging of ligand-receptor binding in PET using a simplified reference region model. Neuroimage. 1997;6:279-287.
35. Talairach J, Tournoux P. Co-Planar Stereotaxic Atlas of the Human Brain. Stuttgart, Germany: Georg Thieme Verlag; 1988.
36. Friston KF, Holmes AP, Worsley KJ. Statistical parametric maps in functional imaging: a general linear approach. Hum Brain Mapping. 1995;2:189-210.
37. Frackowiak RSJ, Friston KJ, Frith CD, Dolan RJ, Mazzlotta JC. Human Brain Function. San Diego, Calif: Academic Press; 1997.
38. Meyer JH, Gunn RN, Myers R, Grasby PM. Assessment of spatial normalization of PET ligand images using ligand specific templates. Neuroimage. 1999;9:545-553.
39. Goodwin GM. Functional imaging, affective disorder and dementia. Br Med Bull. 1996;:52:495-512.
40. Sheline YI, Wang PW, Gado MH, Csernansky JG, Vannier MW. Hippocampalatrophy in recurrent major depression. Proc Natl Acad Sci U S A. 1996;93:3908-3913.
41. Drevets WC, Raichle ME. Neuroanatomical circuits in depression: implications for treatment mechanisms. Psychopharmacol Bull. 1992:28:261-274.
42. 1A agonist. J Pharm Exp Ther. 1996;279:1035-1042.
43. 1A receptors. J Pharm Exp Ther. 1997;282:1581-1590.